---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-031359"
form_type: "8-K"
ticker: "BCTX"
cik: "0001610820"
company_name: "BriaCell Therapeutics Corp."
filed_at: "2023-08-31T23:59:59+00:00"
generated_at: "2026-06-11T01:15:01.556140+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BriaCell closes spinout of BriaPro, distributes shares to existing shareholders

## Summary
- BriaCell completed spinout of BriaPro, receiving 2/3 ownership; shareholders get one BriaPro share and one new BriaCell share per old share.
- BriaPro acquired pipeline assets Bria-TILsRx™ and PKCδ inhibitors for cancer indications.
- New BriaCell common shares expected to begin trading on or about September 5, 2023 under symbol BCT.
- BriaCell remains listed on Nasdaq and TSX; BriaPro is an unlisted reporting issuer in Canada.
- Computershare will distribute certificates; letters of transmittal mailed to registered holders.

## SEC filing metadata
- accession: 0001493152-23-031359
- form_type: 8-K
- ticker: BCTX
- cik: 0001610820
- company_name: BriaCell Therapeutics Corp.
- filed_at: 2023-08-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610820/000149315223031359/0001493152-23-031359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610820/000149315223031359/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-031359
- JSON: https://secwatch.observer/filing/0001493152-23-031359.json
- Plain text: https://secwatch.observer/filing/0001493152-23-031359.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.